GBA's "2021 Stock Phantasma"

AFRM Reminds me alot of Shift 4 Payments a big winner from last thread.
December this is $90.00.

Now what
After last month's sell-off, Affirm shares are trading at a post-IPO low, meaning the stock could be well priced now. In its first earnings report as a publicly traded company, it posted a 55% increase in gross merchandise volume to $2.1 billion, with revenue up 57% to $202.4 million. Revenue minus transaction costs jumped 141%, showing the underlying growth in the business. The fintech is still unprofitable, but margins should improve as it gains scale.

The rotation out of growth stocks will continue, but Affirm looks like a solid bet given its momentum and the fact that its product should be a winner coming out of the pandemic when Americans will be looking to spend money even if their finances might be weak.
 
Good Morning there is alot going on with the virus. Now Pfizer says you will need a third $hot (and a $hot every year!) <--- They had lied about that part continuously. Now we all have to think do we really want that much stuff in our veins....

CureVac shares pop up 6% on Q4 revenue beat; vaccine manufacturing capacity raised to 1B doses in 2022
Apr. 15, 2021 8:49 AM ETCureVac N.V. (CVAC)
  • CureVac(NASDAQ:CVAC) rises 5.6% premarket afterannouncingbusiness updates and financial results for Q4 and FY 2020.
  • Q4 Revenue was €6M, down 11.8% over prior year and FY20 revenue reached €48.9M, an increase of 181% Y/Y.
  • Operating loss was €46.6M and €109.8M for the three and twelve months ended December 31, 2020, respectively, representing an increase of 32.8% and 10.4%, for the same periods in 2019.
  • Cash position as of December 31, 2020 was €1.32B.
  • CVnCoV in final stage of clinical development and is believed to be well on track to provide data for conditional approval based on EMA rolling submission.
  • On March 27, a protocol amendment was filed for the ongoing Phase 2a study in Peru and Panama to enroll ~40 adolescent participants between the ages of 12 and 17. Enrollment is expected to start in April end.
  • An additional Phase 3 trial, to evaluate the safety, reactogenicity and immunogenicity of CVnCoV in adults with an elevated risk of severe COVID-19 infection due to comorbidities is expected to start shortly.
  • Phase 2b/3 in Europe and Latin America is now fully recruited with over 40,000 participants and interim analysis for vaccine efficacy is expected in Q2 2021.
  • In early May, CureVac together with its partner Bayer plans to initiate the Phase 3 study evaluating the safety, reactogenicity and immunogenicity of CVnCoV co-administered with a licensed quadrivalent influenza vaccine in adults 60 years and older.
  • The company expanded manufacturing network with European partners and expects to manufacture up to 300M doses of CVnCoV by end of 2021.
  • For 2022, CureVac raised its capacity guidance from up to 600M to up to 1B doses.
  • Earlier, CVAC has inked COVID-19 collaborations with Bayer,GlaxoSmithKline and Novartis for manufacturing and development of the vaccine.
 
The Golden ticket. = A Universal Covid vaccine.


The aim is for the next generation of new vaccines to be used to either protect people who have not been vaccinated or to serve as a booster “in the event that Covid-19 immunity gained from an initial vaccination reduces over time”.

Adam Barker, healthcare analyst at Shore Capital, said: “They’re trying to develop ‘universal vaccines’, ie vaccines targeting multiple respiratory viruses/coronaviruses. That would be a big contribution to the world, but it’s a big ask. The world has tried for many years to get universal flu vaccines, but they’re technically hard to develop. So this is a high-risk, high-reward strategy.”

GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic.

The two companies said they planned to work jointly to develop a shot next year that could address “multiple emerging variants in one vaccine”.
 
Last edited:
All 3 Of These Are Buys... They are GBA approved stocks!>>>>>>>>

Red Rock Resorts price target raised to $41 from $34 at Deutsche Bank 06:58 RRR

Northern Oil and Gas initiated with a Buy at Citi 06:32 NOG

Affirm upgraded to Buy from Neutral at Seaport Global 06:15 AFRM Seaport Global analyst Chris Brendler upgraded Affirm to Buy from Neutral with an $80 price target.
 
ShiftPixy teases Friday announcement 15:30 PIXY ShiftPixy shared a video via Twitter with a caption reading, "One more day till Friday. Stay tuned. #TikTok #ThursdayMotivation"

Sometimes you catch a glimpse of the future and it aint so great.
A few blocks away from me there is an upscale housing project Peter Cooper Village bunch of big buildings and the NYC police went there to get some guy out of his apartment and they brought with them their robot dog.

It did not go well. Although kids walked up to it and treated it like a real dog the residents of Peter Cooper were not happy. Many complaints have rolled in & unfortunately the very first impression we have of these robots is HIGHLY NEGATIVE!

Quite frankly the police blew this big time. If you want to sneak robots into the equation you have to elaborately set up a fake fire and have one of these robots save a cat.. that image of it rolling out of the building with a singed cat is what New Yorker's want to see... NOT a buzzing lighting, whirling, high stepping jack dog made of metal. Who knows what type of gas and weapons he has hidden inside, what a little terror. VERDICT- No Thanks!

 
Clarification-- On Red Rock.

RRR-- We already had this for a big gain off the bottom and sold it right about where it is now it has been having a hard time with this price area of $33-$34>

My thesis for selling is actually an interesting one. As more folks start going back to these hotels/casinos, the operators of these resorts are forced to spend more opening parts of the hotel that are closed. So that giant pool & light show that they kept shut down for Covid.. that has to be fired up as well as many other costly extras, more food options, etc. All the amenities that that sets one hotel above the next. During the waning days of the Covid Vegas exodus these Casinos operated at less than 50% occupancy but they cut those extras like crazy they really brought down costs to make their earnings # RRR included.

LAS VEGAS, April 9, 2021 /PRNewswire/ -- Red Rock Resorts, Inc. ("Red Rock Resorts", "we" or the "Company") (NASDAQ: RRR) announced today that it will release the Company's financial results for the first quarter 2021 on Tuesday, May 4, 2021 and will hold a conference call on the same day at 4:30 p.m. ET (1:30 p.m. PT). <------ RRR EARNINGS MAY REFLECT THAT INCREASED SPEND SO WAIT TIL THE REPORT! ~stoney
 
Thinking hard about Sprouts Farmers Market... I like Casey General Store but it's quite expensive. Sprouts gives us entre into the same idea even better in some ways.

Did you notice Joe Terranova the other day give the guy credit he came back on and said I'm out of SCR... I'm down 9% and stopped out. Props! That was the Canadian gaming play... since SCR started down GMVHY and (F) has started going up? Coincidence?
 
You must log in or register to reply here.
Back
Top